KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Non-Current Debt (2019 - 2025)

Evolent Health (EVH) has 7 years of Non-Current Debt data on record, last reported at $1.1 billion in Q3 2025.

  • For Q3 2025, Non-Current Debt rose 75.9% year-over-year to $1.1 billion; the TTM value through Sep 2025 reached $1.1 billion, up 75.9%, while the annual FY2024 figure was $490.5 million, 17.84% down from the prior year.
  • Non-Current Debt reached $1.1 billion in Q3 2025 per EVH's latest filing, up from $648.5 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.1 billion in Q3 2025 and bottomed at $202.1 million in Q1 2021.
  • Average Non-Current Debt over 5 years is $490.9 million, with a median of $597.0 million recorded in 2023.
  • Peak YoY movement for Non-Current Debt: fell 18.1% in 2021, then skyrocketed 123.74% in 2023.
  • A 5-year view of Non-Current Debt shows it stood at $215.7 million in 2021, then soared by 91.48% to $413.0 million in 2022, then soared by 44.57% to $597.0 million in 2023, then dropped by 17.84% to $490.5 million in 2024, then surged by 115.04% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $1.1 billion in Q3 2025, $648.5 million in Q2 2025, and $647.5 million in Q1 2025.